Publisher

Since 1993, BioCentury Publications, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures. BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets. BioCentury's Editorial and Research staff comprise industry-recognized business and science editors and writers. The Company's management team includes executives with backgrounds in international business, publishing, finance, and the biotech and pharmaceutical industries. BioCentury is headquartered in Redwood City, Calif., with offices in Washington, D.C.; Chicago; Chadds Ford, Penn.; and London. › The BioCentury Publications BioCentury, the Bernstein Report on BioBusiness is the Company's flagship publication, serving a worldwide audience in the biopharma, investment and public policy communities. This audience values BioCentury's independence, fact-based reporting, strategic perspective and in-depth approach to industry-shaping events. The standards set by BioCentury, the Bernstein Report on BioBusiness have been carried over into each new publication and service added to the Company's multimedia platform. BioCentury Extra is published every business day to be viewed on mobile devices or online, providing busy executives and investors with a concise report of key industry news events that are selected for importance by BioCentury's experienced editors. SciBX: Science-Business eXchange is a joint publishing venture with Nature Publishing Group that identifies commercially promising translational science and assesses the next steps required to develop the technology. Every week, BioCentury and NPG senior business and science editors analyze life science research published around the globe to provide the SciBX audience in R&D, business development, academia and the venture capital community with an early lead on fresh science with investment potential. BioCentury Week in Review provides a weekly compendium of biopharma deals, clinical and regulatory events, and financial transactions. BioCentury Quarterly Stock Roundup tracks more than 500 public biotech companies in the U.S., Europe, Canada and the Asia-Pacific region. This data-rich compilation records the performance of 44 industry subgroups, the BioCentury 100 Index and other benchmark indices and each quarter's fundraising activity.